Ionis Pharmaceuticals, Inc.
IONS
$33.53
$1.273.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.15B | 2.30B | 2.49B | 2.09B | 2.21B |
| Total Receivables | 39.71M | 92.19M | 17.93M | 27.26M | 5.14M |
| Inventory | 11.50M | 12.51M | 28.45M | 28.72M | 30.26M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 219.49M | 212.67M | 176.50M | 187.86M | 165.60M |
| Total Current Assets | 2.42B | 2.62B | 2.71B | 2.33B | 2.42B |
|
|
|||||
| Total Current Assets | 2.42B | 2.62B | 2.71B | 2.33B | 2.42B |
| Net Property, Plant & Equipment | 262.19M | 256.11M | 246.93M | 242.84M | 242.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 90.80M | 86.26M | 79.30M | 77.88M | 63.04M |
| Total Assets | 2.81B | 3.00B | 3.08B | 2.69B | 2.76B |
|
|
|||||
| Total Accounts Payable | 17.46M | 42.96M | 9.05M | 9.24M | 13.08M |
| Total Accrued Expenses | 129.31M | 178.05M | 164.95M | 149.35M | 127.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.30M | 9.28M | 54.50M | 53.22M | 54.37M |
| Total Finance Division Other Current Liabilities | 81.22M | 79.02M | 76.06M | 94.35M | 132.62M |
| Total Other Current Liabilities | 81.22M | 79.02M | 76.06M | 94.35M | 132.62M |
| Total Current Liabilities | 250.29M | 309.32M | 304.57M | 306.16M | 327.65M |
|
|
|||||
| Total Current Liabilities | 250.29M | 309.32M | 304.57M | 306.16M | 327.65M |
| Long-Term Debt | 1.79B | 1.79B | 1.77B | 1.77B | 1.76B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 159.39M | 161.81M | 168.37M | 166.44M | 168.67M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 140.68M | 156.50M | 173.78M | 188.70M | 215.09M |
| Total Liabilities | 2.34B | 2.42B | 2.42B | 2.43B | 2.47B |
|
|
|||||
| Common Stock & APIC | 2.90B | 2.87B | 2.83B | 2.30B | 2.27B |
| Retained Earnings | -2.40B | -2.25B | -2.15B | -2.00B | -1.94B |
| Treasury Stock & Other | -28.95M | -30.81M | -24.17M | -34.84M | -34.96M |
| Total Common Equity | 475.73M | 588.35M | 662.47M | 263.70M | 296.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 475.73M | 588.35M | 662.47M | 263.70M | 296.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 475.73M | 588.35M | 662.47M | 263.70M | 296.52M |
|
|
|||||